Oncology

Myelofibrosis

Advertisement

Conference Reporter® in Myelofibrosis to Cover Key Topics Being Presented at the 2026 ASCO Annual Meeting

conference reporter by Aaron T. Gerds, MD, MS; Raajit K. Rampal, MD, PhD
Overview

Conference Reporter delivers health care providers with insights from key thought leaders on exciting news presented at major medical conferences, in a concise and timely format. Conference Reporter will feature community-selected experts and topics in Myelofibrosis presented at the 2026 ASCO Annual Meeting.


VIEW THE TOPICS:

 

  • Investigational Agents and Recent Advances in Therapy in Myelofibrosis
  • MOA of JAK Inhibitors and Novel MOAs in Myelofibrosis
  • Progressive Disease in Myelofibrosis
  • Risk Assessment and Prognosis in Myelofibrosis

 

This information is brought to you by Engage Health Media and is not sponsored, endorsed, or accredited by the American Society of Clinical Oncology.

 

2026 ASCO Annual Meeting

May 29 – June 2, 2026

McCormick Place

Chicago, IL

Registration Link

Aaron T. Gerds, MD, MS

Associate Professor of Medicine
Cleveland Clinic Lerner College of Medicine
Deputy Directory for Clinical Research
Cleveland Clinic Taussig Cancer Institute
Deputy Associate Director for Clinical Research
Case Comprehensive Cancer Center
Case Western Reserve University
Cleveland, OH

Raajit K. Rampal, MD, PhD

Associate Member
Director, Myeloproliferative Neoplasms Program
Director, Center for Hematologic Malignancies
Memorial Sloan Kettering Cancer Center
New York, NY

Advertisement